Hera Biotech, a San Antonio-based startup developing a nonsurgical diagnostic test for endometriosis, won the Pitch Perfect contest at MedCity News’ INVEST Digital Health conference. The average diagnostic delay for the endometriosis is eight years, driven in large part by the fact that the only method currently used to diagnose the disease is a surgical procedure.
Femtech was the theme of the INVEST Digital Health Pitch Perfect contest in Dallas this week. Seven companies presented their approaches to addressing women's health.
Femtech is the theme for the INVEST Digital Health Pitch Perfect competition in Dallas October 26. Seven startups will share the spotlight and present their approaches to improving women's healthcare. Register today!
Hera Biotech Announces First Patient Enrolled in Endometriosis Diagnostic Study - read this article along with other careers information, tips and advice on BioSpace